Cargando...

Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice

Obesity is a primary risk factor for multiple metabolic disorders. Many drugs for the treatment of obesity, which mainly act through CNS as appetite suppressants, have failed during development or been removed from the market due to unacceptable adverse effects. Thus, there are very few efficacious...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu, Xing Xian, Watts, Lynnetta M., Manchem, Vara Prasad, Chakravarty, Kaushik, Monia, Brett P., McCaleb, Michael L., Bhanot, Sanjay
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726752/
https://ncbi.nlm.nih.gov/pubmed/23922646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0066923
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!